A Study to Investigate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy With GenSci122 in Participants With Advanced Solid Tumors
A Study to Investigate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy With GenSci122 in Participants With Advanced Solid Tumors
Recruiting · NCT06772415 · Registry updated 2025-01-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Investigate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy With GenSci122 in Participants With Advanced Solid Tumors | Advanced Solid Tumor | Recruiting | Phase 1 | 2025-01-22 | NCT06772415 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Changchun GeneScience Pharmaceutical Co., Ltd. | 50 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Cancer Hospital | Beijing | China | 8 |
| Cancer Hospital Chinese Academy of Medical Sciences | Beijing | China | 71 |
| Cancer Hospital of Shandong First Medical University | Jinan | China | 20 |
| Henan Cancer Hospital | Zhengzhou | China | 76 |
| Hunan Cancer Hospital | Changsha | China | 123 |
| Jiang Su Province Hospital | Nanjing | China | 2 |
| The First Affiliated Hospital of ZhengZhou University | Zhengzhou | China | 2 |
| Tianjin Medical University Cancer Institute & Hospital | Tianjin | China | 58 |
| Zhongshan Hospital Fudan University | Shanghai | China | 38 |